Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?

Tonix Pharmaceuticals stock is down on Monday after shares of TNXP underwent a one-for-32 reverse stock split to avoid delisting.

Wake Up! 3 Lesser-Known Stocks Investors Are Sleeping On

Under-the-radar stocks offer incredible chances at massive returns with these shares representing compelling choices for investors.

The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024

Undervalued stocks under $50 hold significant appeal, but as every investor knows, value is in the eye of the beholder

Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm

You can use the wisdom of crowds and their fear and greed motives to profit from these three stocks to buy with plenty of room to run.

Why Is Geron (GERN) Stock Up 18% Today?

Geron stock is up on Friday with heavy trading of GERN shares after the FDA approved the company's blood cancer treatment.

Why Is Virax Biolabs (VRAX) Stock Down 15% Today?

Virax Biolabs stock is down on Friday as shares of VRAX come off of a massive rally yesterday that didn't come with any news.

Why Is Biomea Fusion (BMEA) Stock Down 63% Today?

Biomea Fusion stock is falling on Friday after investors learned of the FDA placing a clinical hold on its Phase I/II clinical trials.

Why Is Venus Concept (VERO) Stock Up 100% Today?

Venus Concept stock is rocketing higher on Friday alongside heavy trading of VERO shares after it regained listing compliance yesterday.

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar

These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.

The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash

Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty.

Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations

For those seeking blistering returns in a relatively short amount of time, short-squeeze stocks may be the go-to place. Here, contrarians leverage the power of…

Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?

Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.

Trade of the Day: Cutera (CUTR) Stock Presents a Short Squeeze Opportunity

Although Cutera’s implosion over the past year is ugly, the bears may have pushed their leverage too far. This bodes well for CUTR stock.

Why Is Virax Biolabs (VRAX) Stock Up 115% Today?

Virax Biolabs stock is up on Thursday alongside heavy pre-market trading of VRAX shares despite a lack of news from the company.

Exit Strategy: 3 Overvalued Stocks to Sell Before They Deflate

These are the overvalued stocks to sell. They represent quality companies that are worth buying after a 20% to 30% downside.

7 F-Rated Stocks to Avoid at All Costs in June

For many people, the most important thing about investing is knowing which stocks to buy, and when to buy them. If you’re a buy-and-hold investor,…

7 Stocks That Could Safely 10X by 2030

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Growth Stock Goliaths: 7 Picks That Will Tower Over the Competition

Investors who want to put some sizzle in their portfolios should consider investing in these growth names that offer big returns.

Hedge Fund Favorites: 7 Stocks to Buy When You’re Feeling Jittery

With the market entering a historically challenging season (due to the adage buy in May and go away), jittery investors may want to turn to…